Synaptic adhesion molecules play a crucial role in the regulation of synapse development and maintenance. Recently, several families of leucine-rich repeat (LRR) domain-containing neuronal adhesion molecules have been characterised, including netrin-G ligands, LRRTMs and the synaptic adhesion-like molecule (SALM) family proteins. Most of these are expressed at the excitatory glutamatergic synapses, and dysfunctions of these genes are genetically linked with cognitive disorders, such as autism spectrum disorders and schizophrenia. The SALM family proteins SALM3 and SALM5, similar to SLITRKs, have been shown to bind to the presynaptic receptor protein tyrosine phosphatase (RPTP) family ligands. Here, we present the 3.1 Å crystal structure of the SALM5 LRR-Ig-domain construct and biophysical studies that verify the crystallographic results. We show that SALM1, SALM3 and SALM5 form similar dimeric structures, in which the LRR domains form the dimer interface. Both SALM3 and SALM5 bind to RPTP immunoglobulin domains with micromolar affinity. SALM3 shows a clear preference for the RPTP ligands with the meB splice insert. Our structural studies and sequence conservation analysis suggests a ligand-binding site and mechanism for RPTP binding via the dimeric LRR domain region.
Introduction
Synaptic adhesion molecules play an important role in the regulation of synapse development and maintenance, including the formation of early synapses and their differentiation into mature synapses (Südhof, 2008; Missler et al., 2012) . These molecules are present on either presynaptic or postsynaptic side of the synaptic cleft on the neuronal cell membrane and contribute to the regulation of synapse development through trans-synaptic adhesion, either via homophilic interactions, as in the case of e.g. the NCAMs (Kallapur and Akeson, 1992) or heterophilic interactions, such in the case of e.g. the neurexin and neuroligin (Sudhof, 2017) . A large number of leucine-rich repeat (LRR)-containing synaptic adhesion molecules such as the LRRTMs (Lauren et al., 2003) , netrin-G ligands (NGLs) (Woo et al., 2009) , synaptic adhesion-like molecules (SALMs) (Nam et al., 2011) and SLITRKs (de Wit and Ghosh, 2014) have been identified to be involved in synapse formation and maintenance, in particular in the excitatory synapses of the brain.
The SALM family of proteins consists of five members (SALM1-5) (Nam et al., 2011) . They share a similar domain structure, containing seven LRRs, an immunoglobulin (Ig) domain and a fibronectin type III (Fn) domain in the extracellular region, a single transmembrane helix and a cytoplasmic tail. In particular, subsets of SALMs (SALM1-3) possess a C-terminal type-I PDZ binding motif that can bind to PDZ domains of postsynaptic density protein PSD-95. All five SALMs are mainly expressed in brain and have been implicated in the regulation of synapse development and function. SALM1 has been suggested to interact with other SALM proteins and to interact with GluN1 subunit of NMDA receptors (NMDARs). SALM1 has further been reported to promote dendritic clustering of NMDARs in cultured neurons (Wang et al., 2006) . SALM2 associates with both NMDARs and AMPA receptors (AMPARs), and promotes the development of excitatory synapses (Ko et al., 2006) . SALM3 and SALM5 specifically induce both excitatory and inhibitory presynaptic differentiation in contacting axons via trans-synaptic interactions with type IIa presynaptic leucocyte antigen-related (LAR) family receptor protein tyrosine phosphatases (RPTPs) (Li et al., 2015; Choi et al., 2016) .
The LAR-RPTPs consist of three members in vertebrates: LAR, RPTPσ and RPTPδ, and each member contains three Ig and four to eight fibronectin type III repeats and have multiple splice variants with short inserts at mini-exon A, B and C sites (meA, meB and meC) in the extracellular region, with meA and meB in the Ig2 domain and between the Ig3 and Ig3-domains, respectively, and possess two tandem intracellular protein tyrosine phosphatase domains (see e.g. Takahashi and Craig, 2013; Um and Ko, 2013) . LAR-RPTPs form multiple trans-synaptic adhesion complexes with various postsynaptic binding partners, including NGL-3 (Woo et al., 2009 ), SALM3 and SALM5 (Li et al., 2015; Choi et al., 2016) neurotrophic receptor tropomyosin-related kinase C (TrkC) (Takahashi et al., 2011) , interleukin-1-receptor accessory protein-like1 (IL1RAPL1) (Yamagata et al., 2015a (Yamagata et al., , 2015b , interleukin-1 receptor accessory protein (IL1RAcP) and SLITRKs (1-6) (Takahashi et al., 2012; Um and Ko, 2013; Yim et al., 2013) . Thus, they appear to act as presynaptic hubs for synaptic adhesion and signalling. They can also act as signalling co-receptors for glypicans (Um and Ko, 2013) .
SALM3 and SALM5 interact with the Ig-domains of all three members of LAR-RPTP family and have been reported to promote both the excitatory and inhibitory synapse development (Li et al., 2015; Choi et al., 2016) . Intriguingly, SALM3 binds RPTP splice variants with insert at the meB site (Li et al., 2015) , whereas SALM5 appears to bind to LAR-RPTPs independent of alternative splicing events at the meB site . A recent study showed that SALM4 suppresses excitatory synapse development by cis-inhibiting trans-synaptic adhesion interaction be SALM3 and LAR-RPTP (Lie et al., 2016) . Further, SALM1 and SALM5 have been implicated in severe progressive autism and familial schizophrenia Morimura et al., 2017) .
The lack of a high-resolution structure for the SALM synaptic adhesion proteins has limited the understanding of how SALMs act in synapse formation and maintenance. Investigating the detailed molecular mechanisms underlying the SALM synaptic adhesion and other functions will be crucial for further analysis of the biological function of these proteins. In the current study, we report the crystal structure of SALM5 extracellular LRR-Ig domain fragment, together with biophysical characterisation of the protein family and binding to presynaptic ligand RPTPσ and its meB splice insert variant. Based on this, we suggest a molecular model for the oligomerization and function of the SALM proteins in synaptic adhesion.
Methods
Cloning, expression and purification SALM and RPTP protein constructs
The mouse SALM gene constructs (SALM1 LRR-Ig-Fn 20-518 , SALM3 LRR-Ig 17-367 , SALM3 LRR-Ig-Fn 17-510 , and SALM5 LRRIg 18-376 and SALM5 LRR-Ig-Fn 18-505 ) and mouse RPTPσ constructs (RPTPσ Ig1-3 33-327 and RPTPσ Ig1-3meB 33-331 ) were cloned into Drosophila pRMHA3 expression vector (Bunch et al., 1988) . The cDNAs for SALM3 and SALM5 were obtained from ImaGenes GmbH, SALM1 and RPTPσ cDNAs were a kind gift from Dr Juha Kuja-Panula. The expression constructs included a CD33 signal sequence at the N-terminus of the insert and a Cterminal Fc tag with a preceding PreScission protease cleavage site. The oligonucleotide primer pairs used for cloning are listed in Table S1 .
The SALM and RPTPσ protein constructs were expressed from stably transfected Drosophila S2 cells. Expression was verified by transient transfection using western blot method with goat polyclonal antihuman IgG horseradish peroxidase-conjugated antibody (Abcam ab98567). All constructs except SALM5 LRR-Ig-Fn 18-505 were successfully expressed and were further produced from stable cell lines. For expression from stable cell line of S2 cells, 1.25 × 10 6 cells per well were plated on a six-well plate at room temperature. After 24 h, the cells were transfected with 4 μg of DNA containing 1:20 part of selection plasmid pCoHygro. The DNA was diluted into 400 μl of the medium; 8 μl of TransIT insect reagent (Mirus Bio LLC) was mixed with the DNA, and the mixture was incubated for 20 min and added to the cells. After 3 days, the selection was started; the cells and medium were centrifuged and the cells were resuspended into medium with 0.3 mg/ml hygromycin and replated into the same wells. The selection was continued for 3 weeks, with media changed every 6 days, in the same cell culture plate. After 3 weeks, the cells were amplified by splitting them first in low split ratios. The cells were amplified every 6 days until the cell viability was above 95%.
For large-scale purification from stable cell lines, the S2 cells were divided 1:10 into HyQ-SFX (GE Healthcare) medium supplemented with 0.15 mg/ml hygromycin, grown in shaker at 25°C for 1 day, and induced with 0.7 mM CuSO4, and expression was conducted for further 6 days, after which the medium was harvested and cells were pelleted by centrifugation at 7000 rpm for 20 min at 4°C. The protein was purified using the C-terminal Fc-fusion tag with protein-A sepharose (Invitrogen). Samples were eluted with 0.1 M glycine (pH 3.0) directly to neutralising buffer, 60 mM Tris (pH 7.4) and 300 mM NaCl. The tagged proteins were incubated with PreScission protease for 16 h at 4°C to remove the Fc tag. PreScission protease was produced as a GST fusion in Escherichia coli BL21 (DE3) using plasmid construct developed in pGEX-6P-1 vector and affinity purified with glutathione sepharose (MachereyNagel). Cleaved Fc-fusion proteins were passed through a protein-A column, and flow-through containing the cleaved SALM or RPTPσ was collected and gel filtered with Superdex 200 10/300 (GE Healthcare) in 60 mM Tris (pH 7.5) and 300 mM NaCl and concentrated, flash-frozen in liquid nitrogen and stored at −80°C for further use.
Binding affinity measurements and biophysical characterisation
Surface plasmon resonance (SPR) measurements on the interaction of SALM3 and SALM5 with RPTPσ variants were carried out using the Biacore T100 system (GE Healthcare) at 25°C. Fc-tagged SALM3 LRR-Ig-Fn (25 μg/ml) and SALM5 LRR-Ig (25 μg/ml) proteins were immobilised onto a CM5 chip (GE Healthcare) with amide coupling chemistry according to manufacturer's instructions and using the running buffer containing 20 mM HEPES (pH 7.5), Ig1-3 and RPTPσ Ig1-3 meB, were tested for binding against SALMFc fusion proteins. The concentrations of RPTPσ and RPTPσ-meB ranged from 0.02 μM to 50 μM.
The size-exclusion chromatography-coupled multi-angle static laser light scattering (SEC-MALLS) was used for the characterisation of the oligomerization and monodispersity of the SALMs and RPTP variants. The measurements were done at 0.5 ml/min over an S-200 Superdex 10/300 column (GE Healtcare) in 20 mM Tris (pH 7.4) and 150 mM NaCl with a HPLC system (Shimadzu) and a MiniDAWN TREOS light scattering detector, and Optilab rEX refractive index detector (Wyatt Technology Corp.). Data were then analysed with ASTRA 6 software (Wyatt Technology Corp.). Proteins were analysed at 1 mg/ml in 50-100 μl volume, expect for SALM3:RPTPσ-meB complex, which was measured at molar ratio of 60:80 μM.
Crystallisation and structure determination and refinement SALM5 LRR-Ig construct was concentrated to 8.5 mg/ml and exchanged to 20 mM Tris pH 7.4 and 100 mM NaCl for crystallisation. Initial crystals appeared from 0.1 M sodium citrate pH 5.5, 20% w/v PEG 1500 at +20°C, and were further optimised to 0.1 M sodium citrate pH 5.0, 20% w/v PEG 1500, 0.01 M CuCl 2 at +4°C. Crystals were harvested with the addition of 10% ethylene glycol or glycerol and flash-frozen for data collection. The crystals diffracted to ca. 3.1 Å at best and crystallised in space group F4 1 32, with one monomer in the asymmetric unit (Table I) . The SALM5 crystal structure was solved using the BALBES automated molecular replacement pipeline with CCP4 (https://www. ccp4.ac.uk/ccp4online/) (Long et al., 2008) . Molecular replacement via the BALBES pipeline was able to find an initial solution for the LRR domain of SALM5, using the LRR domain of AMIGO-1 as the initial template (PDB:2XOT) (Kajander et al., 2011) as a template, but no solution for the Ig-domain. After molecular replacement and initial refinement with REFMAC (Murshudov et al., 2011) , the R-factors for the initial LRR domain model were R work / R free = 43.2%/45.9%. Subsequently, several runs of the autobuild function in phenix software suite (Terwilliger et al., 2008) and 'morphing' (Terwilliger et al., 2013) were used to initially build the model from scratch using the molecular replacement solution to correct the model and trace partially the Ig-domain during the refinement. Finally, the Ig-domain was modelled using Swissmodeller (Bordoli et al., 2009) , and the best minimal model was aligned with the partial crystal structure model built in the 2Fo-Fc electron density traceable for the Ig-domain and re-refined with the autobuild 'rebuild-in-place' and 'morphing' options in phenix. All of these were done with several iterative cycles of model building with Coot (Emsley and Cowtan, 2004 ) with most of the surface side chains and the loop between Ile328 and Leu335 removed during building due to lack of density. This way a model for the Ig-domain was completed and final rounds of refinement were done with BUSTER (Bricogne et al., 2017) . Final R-factors were R work /R free = 25.2%/28.2% and model had geometry restrained to standard expected quality (Table I) .
Small-angle X-ray scattering data collection and analysis
Small-angle X-ray scattering (SAXS) data on the proteins were measured for SALM5 in batch mode at Diamond Lightsource on the B21 beam line, and for SALM3 at the ESRF beam line BM29 (Table S2 ). SALM5 sample was measured in 30 mM Tris-Cl pH 7.5, 150 mM NaCl, 3% glycerol at 1, 3 and 5 mg/ml in 50 μl volume. The SALM3 samples were measured by SEC-SAXS. Sample compartment and exposure cell were cooled to 4°C (Table S2 ). An SD200 10/300 GL (GE Healthcare) column was used at 0.5 ml/min in 20 mM Tris HCl pH 7.5, 100 mM NaCl, 0.02% NaN 3 . For the SALM3 LRR-Ig construct, 45 μl of sample at 8.8 mg/ml was used for SEC-SAXS analysis and for SALM3 LRR-Ig-Fn 47 μl of 15.6 mg/ml sample. Data processing was performed automatically using the EDNA online data analysis pipeline using tools from the ATSAS 2.5.1 (Incardona et al., 2009 ) generating radially integrated, calibrated and normalised 1D profiles for each frame. DATASW Residues with Consurf-server scores: 9* and 10. Fig. 2 The SALM5 dimer interface formed by the LRR domains. Residues involved in dimer interface contacts are labelled, for further details see text. In the middle of the interface a conserved set of polar residues contribute to hydrogen bonding between the monomers, towards the N-and C-termini of the monomers at the dimer interface more hydrophobic interactions contribute to the interface formation. Monomers are shown in light grey and blue, N-T = N-terminus. Ig-domain is hidden behind the plane of the paper. (Shkumatov and Strelkov, 2015) was used for the calculation of the invariants I(0), R g , and molecular weights (M w ). For SALM3 constructs, an elution profile was generated with the I(0)/R g variation plotted versus recorded frame number. The averaged data, corresponding to frames where R g is stable and shows linearity, were further processed using ATSAS package (Petoukhov et al., 2012) . PRIMUS software from the ATSAS software suite version 2.8.0 was used for primary data processing (Franke et al., 2017) . Parameters for each sample are given in Table S2 . Glycans were added to the models with the GlyProt server (www.glycosciences.de/modeling/glyprot/php/ main.php).
Ensemble optimisation method from ATSAS package was used with default parameters ('Random-coil' chain type) resulting in a random pool of 10 000 C-α trace models. Next, a computational pipeline FULCHER (Shkumatov A. et al., unpublished data) was used to convert C-alpha trace models to all-atom models, with subsequent model validation using the MOLPROBITY clash score of 40. Finally, the genetic algorithm GAJOE was run 10 times to obtain an ensemble of models that best describes the experimental SAXS data.
Results and Discussion
Overall structure of SALM5 reveals a dimeric assembly
We have solved the structure of SALM5 at 3.1 Å resolution. The protein crystallised in the cubic space group F4 1 32 (see Table I ). The structure reveals a typical extracellular LRR domain with the LRRNT and LRRCT-capping subdomains with two stabilising disulphides each, and seven LRR repeats between these. Based on sequence data, it has been unclear whether there was six or seven LRR repeats, the structure confirms the presence of seven LRR repeats. Overall, the extracellular LRR domains tend to be highly variable in size, e.g. the neuronal LRRTMs have 10 LRR repeats (Lauren et al., 2003) , others have less, e.g. Slit LRR domains have 4-6 repeats (Rothberg et al., 1990) , while Toll-like receptors have 19-25 repeats (Botos et al., 2011) and several proteins have consecutive separate LRR domains in figure: The alignment of the seven repeat LRR domains (GPIba in yellow and SALM5 in grey). Lower figure: the crystal structure of the SALM5 LRR-Ig fragment with the disordered loop Gln216-Phe233 modelled (in dark grey). The arrow indicates the loop insertion at the start of the LRRCT-capping subdomain in SALM5, while the insert in GPIba is in the middle of the LRRCT. N-T; N-terminus. Structures were aligned and molecular images made with PyMoL.
tandem, such as SLITRKs and Slits (Rothberg et al., 1990; Beaubien and Cloutier, 2009 ). All eukaryotic extracellular LRR domains share the disulphide-linked capping domains at the N-and C-termini of the LRR domains. Also, combinations of LRR and Ig-domains and LRR and Fn-domains, such as in the SALM family proteins, are common among the neuronal cell surface LRR proteins, which typically reside on the postsynaptic membrane.
In SALM5, the N-terminal LRRNT-capping subdomain (residues Phe17-Arg52) has the structure typical of an extracellular eukaryotic N-terminal-capping motif (Park et al., 2008) . The LRRNT β-hairpin at the N-terminus of the LRR domain β-sheet structure (Fig. 1) has slightly longer β-strands than the rest of the LRR β-sheet. On the other hand, the C-terminal LRRCT-capping subdomain (Gln216-Cys284) is quite divergent from the typical LRRCT structure. It starts with an unusual large insertion, disordered in the crystal structure (Gln216-Phe233) before the last β-strand of the extended LRR domain β-sheet; the first ordered residue is Ala234 (marked in Fig. 1 ). The rest of the LRRCT consists of only one regular α-helix and several turns with two disulphide bridges stabilising it. The capping LRRCT appears to be more loosely packed against the LRR repeats than in related proteins, with irregular secondary structure. The looser structure is possible because of the large insertion in the LRRCT. As is typical, the LRR domain ends at the last Cys-residue of the second LRRCT disulphide (Cys285-Cys246). The other disulphide bridge in the LRRCT is formed by the Cys244 and Cys263 residues.
In the mouse SALM5, LRR domain extra electron density can be seen in the predicted Asn73 N-glycosylation site, but the sugar moiety could not be modelled reliably. The other two predicted N-glycans reside in the Ig-domain at residues Asn330 and Asn339. These are disordered in the crystal structure. Overall, based on their location, it would appear that the glycans do not have functional significance.
The SALM5 Ig-domain (Glu285-His373) follows immediately after the LRRCT-capping subdomain (Fig. 1) . The Ig-domain appears fairly disordered overall and apparently somewhat mobile in the crystal as it has poor electron density with higher B-factors compared to the LRR domain (Table I ). Nevertheless, it was possible to trace its position up to the last residue of the fold, His373, based on the initial partial model (see Methods). Some parts of the Ig-domain are weak in the density and loop between two β-sheets of the lg β-sandwich fold at Ile328 and Leu335 is disordered. A part of typical electron density for the LRR domain is shown in Fig. 1 , covering the region for the first LRR repeat.
The refined crystal structure forms a dimer with C2 symmetry with a subunit interface formed by the LRR domains edge-to-edge, the top surfaces of the LRR β-sheets packed against each other (Fig. 1) , with a surface area of 1046 Å 2 , which is clearly the largest intermolecular interface found in the crystal, as measured with the PISA-server (Krissinel and Henrick, 2007) . Interestingly though, the Ig-domains form trimeric assemblies in the crystal, which might be able to further contribute to possible clustering of the molecules on the membrane. In the full-length protein, the Ig-domain is followed by a linker region of ca. 40 residues (Ile374-Thr413) and a fibronectin type III domain on the extracellular side before the transmembrane helix and cytosolic tail. The dimeric LRR-Ig structure has dimensions of ca. 80 Å x 65 Å x 55 Å.
The LRR domains in the dimer form a shallow bowl-shaped surface towards the synaptic cleft formed (Fig. 1) by the two LRR domain concave surfaces, while the Ig-domains point 'downwards' at almost 90°angle towards the cell membrane from the putative LRR-dimer concave ligand-binding platform, which shows high degree of conservation between the known RPTP-binding SALM3 and SALM5 proteins (Fig. 1) . In total, we find 31 highly conserved residues on the concave surface of the LRR domain beta-sheet from LRRNT to the seven LRR repeats (Table II) . In practice, the whole surface appears highly conserved (Fig. 1) , while the overall sequence identity between the SALM3 and SALM5 proteins is ca. 50-60% and the convex side of the LRRs (or the Ig-domain) does not show significant continuous areas of conservation (Fig. 1) . The dimer interface is partly formed by hydrophobic interactions at the N-and C-termini on the LRR domain (Fig. 2) involving residues Phe62 and Leu43 on one side and Leu260, Ala264 and Thr262 on the other side, partly packing against the peptide backbone turns of the opposing domain. In the middle of the dimer interface, contacts are formed by hydrogen-bonding interactions through side chains of Arg110 and Asn158 from opposing monomers, Arg110 also hydrogen bonds to the backbone carbonyl of Asn157. Gln134 is possibly involved in the hydrogen-bonding network (Fig. 2) but its position could not be accurately modelled in the 3.1 Å resolution 2Fo-Fc electron density map.
Comparison to other LRR proteins
Based on a DALI-search (Holm et al., 2008) , we found several LRR domain proteins with high Z-scores. The highest Z-scores were found for the LRR domain for the Hagfish variable lymphocyte receptor (Z-score 27.6) domain with seven LRRs (PDB:2O6Q) and the platelet glycoprotein Ib alpha (GPlba; PDB:1M0Z) (Z-score (C) Distance distribution function, P(r), estimated for the studied constructs using GNOM. (D) Flexibility assessment: R g distribution for the random pool of models (grey) and for the selected ensemble of conformations that fit the scattering intensity curve (dashed dark blue). (E-G) The ensemble models for dimers of SALM3 LRR-Ig (E, blue), SALM5 LRR-Ig (F, grey) and SALM3 LRR-Ig-Fn constructs (G, multiple colours). Dimers are viewed from the side as in Fig 1b. It can be seen that the Ig-domains form flexible ensembles around the fixed LRR domain dimer. SALM3 LRR-Ig-Fn construct shows significantly increased flexibility, probably due to the linker between the Ig-and Fn-domains. Positions of the Fn-domains in the selected ensemble models are marked for one monomer (in G). Glycans are shown as sticks.
25.9), also with seven LRRs. The GPlba LRR domain aligns with an r.m.s.d. of 1.462 Å with the SALM5 LRR domain (Fig. 3) . Interestingly, both SALM5 and GPlba have a large loop insertion in the LRRCT subdomain, which in the GPlba wraps around the von Willebrand factor ligand, structuring into a β-hairpin structure on ligand binding (Huizinga et al., 2002) . Similarly, the β-sheet of LRRNT is extended in both, and in GPIba bent towards the binding site on the concave surface of its LRR domain inducing larger curvature and wrapping around the ligand. It can be hypothesised that the long insertion loop in SALM5 also might have a functional role in recognition of the ligand, since the insertion at this position is present in the whole SALM protein family.
Also the SLTRK first LRR domain, with six LRRs, aligns well (r.m.s.d. 1.429 Å) with our SALM5 structure-this is notable as both recognise the same RPTP ligands (see below). Previously, we have characterised the structures of the neuronal AMIGO family proteins (Kajander et al., 2011) , which have six LRRs followed by an Ig-domain, but with a different type of dimer arrangement, where the LRR concave surfaces form the dimer interface. The SALM LRR domain dimer appears unique in the known cell surface LRRprotein proteins by forming a continuous double β-sheet surface by the two LRR domains (Fig. 1) .
Biophysical characterisation of SALM family proteins
Solution measurements by SEC-MALLS and SAXS analysis confirm the dimeric nature of SALM family proteins in solution, as dimers were observed for all SALM1 LRR-Ig-FN , SALM3 LRR-Ig , SALM3 LRR-Ig-FN and SALM5 LRR-Ig by SEC-MALLS (Fig. 4) , with observed molecular weights (Mw) of 80.7 and 83.2 kDa for SALM3 and SALM5 LRR-Ig constructs, and 121-122 kDa for the Fn-domain containing constructs. These match well with expected theoretical dimer Mws based on the calculated monomer Mws of 39.8 and 39.1 kDa for the short constructs, as well as the longer ectodomain constructs, which have theoretical Mws of 52 and 54 kDa for a monomer. All theoretical values are without N-glycans, which contribute ca. 3-4 kDa per protein monomer, due to the paucimannose-type glycans present in insect cellproduced proteins (Shi and Jarvis, 2007) .
To further confirm the oligomeric state of SALM proteins in solution, SAXS experiments were performed (Fig. 5 , Table S2 ). The scattering profiles show few features for SALM3 and SALM5 LRRIg constructs and almost a featureless curve in case of the whole SALM3 ectodomain construct (SALM3 LRR-Ig-Fn) (Fig. 5A) . A dimensionless Kratky (dKratky) plot (Fig 5B) reveals two peaks for SALM3 LRR-Ig, whereas the second peak was less pronounced for SALM5 LRR-Ig and almost absent for the SALM3 LRR-Ig-Fn construct, indicating that ectodomain construct is the most flexible among three. Similarly, all P(r) functions present a single peak with a smooth and extended P(r) distribution function, particularly in case of the ectodomain construct (Fig. 5C ). Molecular weight estimation from SAXS curves of SALM3 and SALM5 LRR-Ig constructs indicated values consistent with a dimer model, whereas for SALM3 LRR-Ig-Fn, increased Mw estimates can be due to the presence of the long disordered linker region between the Ig-and the Fndomains (Table S2 , Fig. 5B ).
For the validation of the obtained SALM5 crystal structure, theoretical scattering profiles were calculated for monomer and dimer model of SALM5 and compared to the experimental scattering profile. The resulting fits unambiguously indicated that both LRR-Ig scattering curves resemble dimer state in the crystal (Fig. 5A) . To reconstitute the scattering curves, missing flexible termini were modelled and data were described using an ensemble approach (Bernado et al., 2007) . The obtained fits show excellent agreement to the scattering data (Fig. 5A ). In the case of SALM3 LRR-Ig , R g distribution of the selected ensemble is shifted to the left, suggesting a rather compact structure of the construct, consistent with observed 'bumps' in the scattering curve and the second peak in the dKratky plot (Fig. 5D ). In the case of SALM5 LRR-Ig construct, additional smaller peak was observed (Fig. 5D) , which corresponds to the presence of extended confirmations. The whole SALM3 ectodomain construct (SALM3 LRR-Ig-FN ), on the other hand, shows a rather broad R g distribution of the selected ensemble (Fig. 5D) , indicating higher flexibility as compared to the other two constructs. The conserved structural arrangement between the homologous SALM proteins, as well as the sequence conservation (Fig. 1) , suggests a conserved mechanism of action between at least the SALM3 and SALM5 proteins for ligand binding, as they both bind the same presynaptic RPTPσ ligands.
Ligand binding by SALM3 and SALM5 and model for binding site for RPTP ligands
We determined the binding affinities of SALM3 and SALM5 extracellular domains towards RPTPσ and RPTPσ-meB splice variant by SPR. SALM3 showed a clear preference for RPTPσ-meB splice variant, while for SALM5 the data indicated similar affinities for both (Fig. 6 ). Overall, SALM3 had slightly higher affinity and was more specific towards the RPTPσ-meB ligand, with 10-fold lower affinity observed by SPR for the RPTPσ lacking the mini-exon B between the Ig2-and Ig3-domains of the RPTPσ ligand. For SALM5 only a twofold difference in affinities was observed with or without the meB-insert of RPTPσ. Both proteins had similar low micromolar range affinities for the meBcontaining splice variant ligand (Table III) . Previously, SALM3 has been reported to have a preference for the meB splice variant (Li et al., 2015) . Notably, we also did not observe any binding of SALM1 to SALM3 or SALM5, contradicting the earlier aggregation results (Nam et al., 2011) .
Based on the earlier reported structures of SLITRK in complex with RPTP Ig-domains (Um et al., 2014; Yamagata et al., 2015a Yamagata et al., , 2015b , we decided to compare the two systems. Given the clear sequence conservation pattern among SALM3 and SALM5 proteins when displayed on SALM5 surface (Fig. 1) , it seems obvious that SALMs will also recognise their ligand via the unique concave dimeric LRR domain surface, possibly suggesting a new type of ligand recognition for the LRR adhesion receptors. Overall, LRR domains typically recognise their targets utilising the concave surface (Helft et al., 2011) . In order to compare the two systems, we aligned the SALM5 LRR domain and the SLITRK LRR domains from N-terminus onwards and observed how the RPTP ligand would fit on the SALM dimer 'top' concave surface (Fig. 7) . Obviously, no direct fit is expected, but based on the alignment it can be suggested that the RPTP ligand would not fit very well in a 2:2 complex onto the SALM5 dimer, unless the binding occurs in a very different manner. This would have to involve the non-conserved regions on the LRR domains, away from the dimer interface and the 'top' surface (Fig. 7) . We then performed assays to verify the stoichiometry, and based on the SEC-MALLS analysis (Fig. 4) of the SALM3-PTPσ Ig1-Ig3 complex, peaks corresponding to 2:1 complex and dissociated RPTPσ ligand were observed (Fig. 4) . We therefore suggest that the RPTPσ ligand is recognised with 2:1 stoichiometry.
It is still possible that there is a second binding event with lower affinity that we are unable to observe, which would result in some form of 2:2 complex. Alternatively, it can also be that the low affinity and kinetics of the system only allowed us to detect a 2:1 complex, Nonetheless, it would appear that the 2:1 complex is the major quaternary state for the complex in solution, and thus possibly on the cell surface, based on our SEC-MALLS results.
Conclusions
We show that SALM5 appears to function as a dimeric synaptic organiser molecule-the crystal structure reveals a bowl-shaped top surface formed by the dimerised LRR domains. We find that also SALM1 and SALM3 ectodomains, and therefore most likely the whole protein family, form dimeric structures, presumably via their LRR domains. Our SAXS analysis confirms that SALM3 LRR-Ig fragment has a very similar structure to the SALM5 crystal structure. Both SALM3 and SALM5 in our studies are able to bind the RPTP ligands with meB splice site with similar affinity while SALM3 appears more selective. Based on our results, we suggest a 2:1 stoichiometry for RPTP ligand binding and suggest a ligand-binding site at the extended concave LRR 'double β-sheet' surface of the dimeric SALM ectodomain based on the sequence conservation data and the structural organisation.
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